Takeda Pharmaceutical Co Ltd (NYSE:TAK) Q2 2021 Earnings Conference Call October 29, 2020 5:30 AM ET Company Participants Christopher O'Reilly - IR Christophe Weber - President, CEO & Representative Director Andrew Plump - President, Research & Development and Director Constantine Saroukos - CFO & Director Julie Kim - President, Plasma-Derived Therapies Business Unit Conference Call Participants Fumiyoshi Sakai - Crédit Suisse Hidemaru Yamaguchi - Citigroup Kazuaki Hashiguchi - Daiwa Securities Shinichiro M ...